AK-PENTOLATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ak-pentolate, and when can generic versions of Ak-pentolate launch?
Ak-pentolate is a drug marketed by Epic Pharma Llc and is included in one NDA.
The generic ingredient in AK-PENTOLATE is cyclopentolate hydrochloride. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AK-PENTOLATE?
- What are the global sales for AK-PENTOLATE?
- What is Average Wholesale Price for AK-PENTOLATE?
Summary for AK-PENTOLATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| Patent Applications: | 1,284 |
| DailyMed Link: | AK-PENTOLATE at DailyMed |
US Patents and Regulatory Information for AK-PENTOLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | AK-PENTOLATE | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 085555-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
